Research and Capacity Building Core

研究和能力建设核心

• 批准号: 10738441
• 负责人: Juliet Iwelunmor
• 金额: $ 35.83万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-19 至 2028-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10738441
• 关键词: Adoption; Africa; Awareness; Cancer Burden; Cancer Control; Cancer Control Research; Cancer Science; Cancer Vaccines; Cervical; Cessation of life; Clinical; Collaborations; Communities; Country; Creativeness; E-learning; Equity; Evidence based intervention; Faculty; Fostering; Funding; Geography; Goals; Grant; Health; Healthcare; Hepatitis B Vaccines; Human Papilloma Virus Vaccine; Human Papillomavirus; Hybrids; Immunization; Individual; Institution; Institutionalization; Intervention; Lead; Malignant Neoplasms; Medical Research; Mentors; Mentorship; Methods; National Institute of Child Health and Human Development; Nigeria; Nigerian; Persons; Pilot Projects; Primary carcinoma of the liver cells; Research; Research Personnel; Research Support; Resources; Science; Series; Services; Site; Talents; Training; Travel; United States National Institutes of Health; Vaccines; Writing; Youth; anticancer research; apprenticeship; cancer type; cancer vaccination; career; cohort; community organizations; crowdsourcing; design; evidence base; experience; faculty mentor; implementation research; implementation science; improved; innovation; learning community; next generation; peer support; population health; prevent; programs; prototype; recruit; research to practice; skills; social; supportive environment; training opportunity; virtual

Nigeria, Africa’s most populous country, bears the second highest burden of cancer cases (11%) and deaths (12%) in Africa.1 Evidence-based cancer control interventions such as vaccines for cancer control exist, but are underutilized in Nigeria.2,3 To close this research-to-practice gap, we propose a US-Nigerian Cancer Control Center for Research on Implementation Science and Equity (C3-RISE) capacity building core. The overall goals are to increase the pipeline of early-career Nigerian-based investigators and practitioners who can lead IS research for equitable cancer control in Nigeria. We will use participatory implementation science approaches10 (such as crowdsourcing11 and apprenticeships) to develop sustained capacity for implementation research at the Nigerian Institute of Medical Research. Crowdsourcing asks a group to solve a problem (through participatory activities such as open calls,12 designathons,13 or other activities) and then shares the solutions with the public.14 Apprenticeships provide the practical skills, direct mentorship, and supportive environment to increase the likelihood of launching successful IS interventions. In this capacity building core, we propose a series of in-person and online training opportunities in IS methods to spur innovative, equitable cancer control research pilot studies. Each year, open calls will be used to identify eight exceptional trainees (as part of two-person teams) from participating Nigerian-based institutions (including academic, clinical, and community-based organizations). Each cohort will join a two-week residential training experience focused on IS for equitable cancer control. Trainees will also become part of a year-long virtual learning community and mentoring program designed to facilitate and sustain careers in the IS and cancer workforces. Trainee teams will compete for small seed Pilot Partner grants to launch pilot plans of their final IS cancer pilots at community sites. They will receive mentorship from established faculty mentors to carry out pilots focused on enhancing vaccines to prevent cancer (i.e., HPV and HBV vaccines). Our specific aims are: To identify and recruit Nigerian trainees for the C3-RISE capacity building core ; 2) To develop IS research capacity building for equity in cancer control among trainees; and 3) To initiate, sustain, and evaluate a virtual participatory learning community to facilitate access to curated resources and collaboration between geographically dispersed trainees. Our strong focus on cultivating local Nigerian mentors and trainees will have an enduring impact on institutionalizing research mentorship and enhancing capacity for training at the organizational level. Our plan aligns with Nigerian national, NIH, and strategic priorities related to building capacity for cancer research.

尼日利亚是非洲人口最多的国家，其癌症病例（11%）和死亡负担位居第二 (12%) 在非洲。1 存在基于证据的癌症控制干预措施，例如用于癌症控制的疫苗，但 尼日利亚未得到充分利用。2,3 为了缩小研究与实践之间的差距，我们提出了美国-尼日利亚癌症控制计划 实施科学与公平研究中心 (C3-RISE) 能力建设核心。 目标是增加尼日利亚早期职业调查人员和从业人员的渠道，他们可以领导 尼日利亚公平癌症控制的 IS 研究。我们将使用参与性实施科学。 持续发展实施能力的方法10（例如众包11和学徒制） 尼日利亚医学研究所的研究要求一个小组解决一个问题。 （通过公开征集、12 指定马拉松、13 或其他活动等参与性活动），然后分享 14 学徒制提供实用技能、直接指导和支持 环境以增加成功启动信息系统干预措施的可能性。 我们提出了一系列关于信息系统方法的面对面和在线培训机会，以刺激创新、公平 癌症控制研究试点研究每年都会通过公开征集来确定八名杰出的实习生。 （作为两人团队的一部分）来自尼日利亚参与机构（包括学术、临床和 每个队列将参加为期两周的住宿培训体验，重点关注 公平癌症控制的 IS 学员还将成为为期一年的虚拟学习社区的一部分。 指导计划旨在促进和维持 IS 和癌症劳动力团队的职业生涯。 将争夺小额种子试点合作伙伴赠款，以在社区启动最终 IS 癌症试点的试点计划 他们将接受现有教师导师的指导，以开展重点加强的试点。 我们的具体目标是： 识别和招募预防癌症的疫苗（即 HPV 和 HBV 疫苗）。 C3-RISE 能力建设核心的尼日利亚学员 2) 发展 IS 研究能力建设以促进公平； 学员的癌症控制；3) 启动、维持和评估虚拟参与式学习 社区，以促进获取精选资源以及地理分散的之间的协作 我们对培养尼日利亚当地导师和学员的强烈关注将对我们产生持久的影响。 我们的计划是使研究指导制度化并增强培训能力。 与尼日利亚国家、NIH 和与癌症研究能力建设相关的战略优先事项保持一致。